Invited Speakers

Prof. Dr. Besim Ogretmen
Medical University of South Carolina - United States
Sphingolipid Metabolism and Signaling in Cancer Therapy: Implications in Aging, Neurodegeneration, and Immunotherapy

Assoc. Prof. Atil Bisgin
Cukurova University - Turkey
Liquid Biopsy and Multi-Omics Approach in Clinical Practice

Baris Korkmaz, PhD
INSERM , France
Cathepsin C as Pharmacological Target in Cancer

Bruno Sainz, PhD
Autonomous University of Madrid - Spain
Cancer Stem Cells and Tumor Microenvironment

Prof. Dr. Fahri Saatcioglu
University of Oslo - Norway
Unfolded Protein Response Drives Prostate Cancer

Asst. Prof. Farasat Zaman
Karolinska University - Sweeden
Bone Growth Disorders in Childhood Cancer

Prof. Dr. Gamze Tanriover
Akdeniz University - Turkey
Stopping the Fast Moving Carcinogenesis with the Brakes of Rottlerin

Prof. Dr . Gülinnaz Ercan
Ege University - Turkey
Anti-Cancer Efficiency of Natural Killer Cells Differentiated from Different Human Multipotent Stem Cells

Prof. Dr. Hana Algul
Munich Technical University - Germany
Precision Medicine in Pancreatic Cancer

PD Dr. Dr. Ihsan Ekin Demir
Technical University of Munich - Germany
Organoid Models of Neuronal Invasion of in Cancer

Prof. Dr. Janko Kos
University of Ljubljana - Slovenia
Regulation of NK Cells and CTL in Tumor Microenvironment by Cysteine Cathepsins

Prof. Dr. Jordi Camps
Autonomous University of Barcelona - Spain
Tetraploidy-Associated Intratumor Heterogeneity Promotes Initiation and Progression of Colorectal Cancer

Maurizio Callari, PhD
University of Cambridge - UK
Mass Cytometry Reveals Complex Cellular Phenotypic Diversity in Breast Cancer Xenografts

Assoc. Prof. Mazhar Adli, PhD
Northwestern University - United States
Understanding and Targeting Genome Regulation with CRISPR

Assoc. Prof. Ozgur Kutuk
Baskent University - Turkey
Kinome-wide RNAi Screening for Mediators of ABT-199 Resistance in Breast Cancer Cells Identifies Wee1 as a Novel Therapeutic Target

Assoc. Prof. Ozgur Sahin
University of South Carolina - United States
From Mechanisms of Drug Resistance to Drug Discovery

Assoc. Prof. Sehime Temel
Uludag University - Turkey
Liquid Biopsy Experiences and Fusion Detections an Overview of Bursa Uludag Genetics Lab Experience
Bogazici Uni Panel

Asst. Prof. Tolga Sütlü
Bogazici University - Turkey
Preclinical Development of Personalized Cancer Immunotherapies Using Natural Killer Cells

Prof. Dr. Batu Erman
Bogazici University - Turkey
Structural and Functional Analysis of the Transcription Factor Patz1: Implications for Ewing's Sarcoma

Assoc. Prof. Dr. Tolga Emre
Bogazici University - Turkey
Cancer Epigenetics and IRF4

Prof. Dr. Nesrin Özören
Bogazici University - Turkey
NLRP7 in Molar Pregnancy Disease and Cancers
Koç Uni All Woman Panel

Buse Cevatemre, PhD
Koc University - Turkey
Drug library screening identifies epigenetic modifiers that revert taxane resistance in prostate cancer

Ceyda Acilan, PhD
Koc University - Turkey
How does prostate cancer become taxane resistant? An omics approach

Asst. Prof. Gülnihal Özcan
Koc University - Turkey
Time and order to transform antagonism into synergism for drug combinations in gastric cancer

Assoc. Prof. Tuğba Bağcı Önder
Koc University - Turkey
CRISPR/Cas9-based identification of epigenetic factors that will overcome therapy resistance in cancers